Recent Updates
Recently added Catalysts
BDX Positive Sentiment Score: 75/100

BD to Present at Goldman Sachs 46th Annual Global Healthcare Conference BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Goldman...

Key Takeaway: Becton, Dickinson and Company (BD) will present at the Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025. This event reflects BD's ongoing engagement in advancing healthcare discussions and investor interest. A live webcast of the presentation will be available on BD's investor relations website, and a replay will be accessible afterward. BD continues to position itself as a leader in medical technology and innovation.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is actively participating in a major healthcare conference.
  • The company showcases its commitment to improving healthcare.
  • The presentation could enhance investor relations and engagement.

Full Press Release Details

FRANKLIN LAKES, N.J. , May 27, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it will present at the Goldman Sachs 46 th Annual Global Healthcare Conference on Monday, June 9, 2025 at 2:00 pm Eastern Time .
The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event will be available on the same webpage following its conclusion.
About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ , X (formerly Twitter) @BDandCo or Instagram @becton_dickinson .
Contacts:
Media : Investors :
Troy Kirkpatrick Adam Reiffe
VP, Public Relations Sr. Director, Investor Relations
858.617.2361 201.847.6927
[email protected] [email protected]
SOURCE BD (Becton, Dickinson and Company)

21 %

Frequently Asked Questions

When is BD's presentation at the Goldman Sachs Conference?

BD's presentation will be on June 9, 2025, at 2:00 pm Eastern Time.

Where can I watch BD's presentation live?

The live webcast can be accessed from the BD investor relations website.

Will there be a replay of BD's presentation?

Yes, a replay will be available on the BD investor relations webpage after the event.

What does BD focus on in healthcare?

BD focuses on improving medical discovery, diagnostics, and care delivery.

How many employees does BD have?

BD employs more than 70,000 people worldwide.

Last updated: May 27, 2025